Novartis Sales Rep Says Ordered To Bribe China Doctors For Drug Sales
This article was originally published in PharmAsia News
Executive Summary
A former Novartis sales representative told a China newspaper she was instructed to give hospital physicians a total of more than $8,000 as a way to secure a $104,000 sale of Sandostatin LAR (octreotide) for treating rare gastrointestinal cancers.